Becton Dickinson rises after lifting annual profit forecast

Medical device maker Becton Dickinson's BDX.N shares gain as much as 8.5% to an over 3-month high of $187.18

BDX now expects its 2025 adjusted profit per share between $14.30 and $14.45, compared with its prior range of $14.06 to $14.34

It reaffirms its annual revenue to be between $21.8 billion and $21.9 billion, compared with analysts' estimates of $21.83 billion, according to data compiled by LSEG

Company reported a profit of $3.68 per share on an adjusted basis for the quarter ended June 30, beating estimates of $3.40 per share

Quarterly sales for the company came in at $5.51 billion, above estimates of $5.49 billion

"We think today's update should be enough to satisfy investor expectations," says brokerage J.P.Morgan

*BDX says in a post-earnings call that while the uncertainty for market pressures continues to persist, it expects year-over-year organic revenue growth to improve sequentially in Q4

Including session moves, stock down 17.8% YTD